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ABSTRACT
Objective: High prevalence of diabetes mellitus in Malaysia demands the appropriate interventions to alleviate or postpone its burden on patients’ 
health-related quality of life (HRQoL). The studies which provide useful knowledge about the components of such interventions are important. The 
aim of this study was to describe how demographic and clinical characteristics of diabetes patients influence their HRQoL using EQ-5D.
Methods: This study used the baseline data of a randomized controlled study carried out to examine the impact of a pharmacist intervention on 
poorly controlled diabetes patients. A generic HRQoL tool EQ-5D was used to report the data. Logistic regression was used to identify the predictors 
of problems in individual EQ-5D domains, and ANCOVA was undertaken to examine the effect of patients’ characteristic on EQ-5D mean scores and 
visual analog scale (VAS) mean scores.
Results: Pain discomfort was reported to be significantly predicted by high HbA1c levels. Increasing age (OR =1.04; CI 1.01, 1.16) and increasing 
body mass index (OR = 1.15; CI 1.01, 1.30) were significant predictors of reduced mobility. The presence of complications (OR = 8.03; CI 1.34–48.02) 
and (5–10 years) diabetes duration predicted the reduced score in anxiety domain (OR = 7.05; CI 1.03, 48.04). Problems in usual activities were 
significantly predicted by age (OR = 1.4; CI 1.01, 1.18). Self-care was not affected by any of the model covariates. Mean EQ-5D score was (0.89; CI 0.85, 
0.92) significantly predicted by HbA1c values (p=0.04). Mean VAS score (70.54) was significantly lower in the group receiving insulin (69.46; CI 73.74, 
84.02) than the oral diabetes medication (78.88; CI 64.94, 73.98) (p=0.009).
Conclusion: Patients’ characteristics were significantly associated with the HRQoL in type 2 diabetes. There was a significant and inverse association 
of HRQoL with medication group (insulin use), high HbA1c, obesity, and presence of complications.
Keywords: Health-related quality of life, EQ-5D, Diabetes mellitus, Randomized controlled study.
INTRODUCTION
Diabetes mellitus is a chronic medical condition which affects the people 
of all ages, races, regions, and economic statuses. The global prevalence 
of diabetes has reached the level of diabetes epidemic majorly due to 
population growth, aging, urbanization, and increasing prevalence 
of obesity and physical inactivity [1]. High prevalence of diabetes has 
attracted the researchers to investigate its complications and related 
effects on the life of patients. Health-related quality of life (HRQoL) is 
one such measure that helps in understanding the functional effects of 
a medical condition and/or its consequent therapy on a patient [2]. In 
this context, our study aimed to explore the HRQoL and its predicting 
factors in type 2 diabetes patients at a tertiary care hospital in Malaysia.
Burden of diabetes in Malaysia
The diabetes prevalence has been reported to increase at an alarming 
rate in Malaysia. The burden of diabetes in Malaysia was almost doubled 
to 22.9% in 2013 [3] compared to the 11.6% reported in 2006 [4]. If 
the World Health Organization (WHO) criteria for diabetes diagnosis 
was used, Malays showed the highest proportion with diabetes among 
the ethnic groups. However, when classification was based on the WHO 
criteria as well as an HbA1c >6.5%, the Indians showed the highest 
proportion with diabetes (11.2%) compared with the Malays (5.2%) 
and Chinese (2.4%) [3].
Diabetes and HRQoL
Diabetes has considerable potential to influence HRQoL due to its 
chronic and progressive nature. Previously, several studies have 
demonstrated the negative impact of diabetes’ presence on patients’ 
qualify of life. Significantly lower HRQoL was reported in people with 
diabetes than people without diabetes [5-8]. Progressive nature of 
diabetes is responsible for the development of related comorbidities 
such as foot ulcers, vision impairment, and nephropathy. The presence 
of such comorbidities impairs the quality of life in diabetes patients [9]. 
The burden of reduced HRQoL as a result of diabetes can take a toll 
on the performance of patients’ routine functioning. A study reported 
that the average diabetes patients with lower quality of life were willing 
to trade away 12% of their remaining life in return for a diabetes-free 
health state [10].
Furthermore, the challenging task of managing diabetes involves 
constant adjustments and decision-making regarding the treatment; it 
predisposes the patients to increased psychological work. The findings 
of Scott et al. [11] support the notion of increased psychological 
pressure; the mental component of HRQoL in their study was 
significantly lower in patients with diabetes with poor glycemic control. 
Similar results were also reported in other studies [12,13]. Therefore, 
it becomes imperative to develop strategies and interventions that 
improve the quality of life in diabetes patients.
Clinical markers of diabetes such as HbA1c are frequently reported 
to indicate the disease control. However, holistic view of disease 
control and therapeutic outcomes can only be obtained by assessing 
the HRQoL in addition to the clinical markers. Studies which report 
patient characteristics and predictive factors of HRQoL facilitate the 
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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understanding of pertinent challenges experienced by diabetes patients. 
Identification of modifiable and associated predictive factors of the 
quality of life can facilitate the designing of appropriate interventions for 
improving the same. Most of the previous studies on HRQOL carried out 
in Malaysia report the status of HRQOL and/or analyzed the relationship 
of glycemic control with HRQoL among study participants [14-16]. 
Some studies have investigated the predictors of diabetes-specific 
HRQOL [17,18] and predictors of perception of diabetes-specific 
HRQoL across ethnic groups [19]. However, these studies used disease-
specific HRQoL instruments. One study used a generic instrument 
(SF-36) for the determination of HRQoL predictors [20]. The purpose 
of the present study was to assess the overall HRQoL and predictors of 
HRQoL in poorly controlled diabetes patients at a tertiary care facility 
using a generic HRQoL instrument EQ-5D. There have been concerns 
about the sensitivity of EQ-5D’s capacity to capture the diabetes-related 
HRQoL. However, studies have shown that presence of subjective 
diabetes symptoms correlates significantly with EQ-5D scores, and 
therefore, adding a valuable dimension to the comprehensive HRQOL 
evaluations [21]. Regardless, the preference-based HRQoL instruments 
such as EQ-5D that evaluate health status are frequently used in diabetes 
research. The findings from such studies contribute toward resource 
allocations and related cost-utility analyses. Our study reported the EQ-
5D results as a single summary index (mean scores) and investigated the 
association of EQ-5Dmean scores with patients’ sociodemographic and 
diabetes-related clinical characteristics. There is a scarcity of studies 
from Malaysia which present the EQ-5D results of diabetes as a single 
summary index and explore the related predictive factors. The results of 
the present study may prove helpful in this regard.
Aim
The aim of this study was to investigate the HRQoL in diabetes patients 
using EQ-5D and investigate the association of patients’ characteristics 
with EQ-5D mean scores/visual analog scale (VAS) scores and 5 
domains of EQ-5D.
METHODS
The present study analyzed the baseline data of patients from a 
randomized controlled study [12] conducted at a tertiary care hospital 
in Malaysia. The study was approved by the University Kebangsaan 
Malaysia’s Research Ethics Committee.
EQ-5D
EQ-5D is a preference-based HRQoL instrument which provides a 
generic, simple, and immediate measure of health situation for clinical 
and economic appraisal [22]. It consists of five domains of health 
(mobility, self-care, usual activities, pain, and anxiety) in the descriptive 
system and a VAS. For each domain, participants were asked to pick 
one of three levels to describe their current health state: Level 1 = 
no problem, level 2 = some problem, and level 3 = extreme problem. 
The descriptive values were transformed into a single summary index 
using VAS valuation values provided by a Malaysian study [23]. VAS 
valuation values were preferred over the value sets derived from TTO 
valuation; the researchers found inconsistencies in the latter method 
and suggested value sets derived from VAS valuation would work better 
in the Malaysian setting [23].
Data analysis
Data were entered and analyzed using SPSS version 23. For descriptive 
analysis, sociodemographic and clinical data of participants were 
presented as a percentage, mean, and standard deviations. Age groups 
were based on the simple quartile distribution of the data. Body mass 
index (BMI) groups were based on the reference from the WHO [24].
The predictors of EQ-5D domains were investigated using binary 
logistic regression. Levels 2 and 3 of all 5 EQ-5D domains were 
merged to dichotomize the responses of participants into “level 1 
= no problem” and “level 2 or 3 = some or extreme problem.” Odds 
ratios with 95% confidence intervals were produced and interpreted; 
Chi-square values and Hosmer and Lemeshow statistics (H-L) were 
studied to report goodness of fit in the regression models. The 
covariates entered in the models were specified based on the inputs 
from diabetes educators and academic literature. The missing data for 
model covariates were imputed using multiple imputation commands 
in SPSS.
Analysis of variance and t-test were performed to analyze the mean 
difference in VAS and EQ-5D scores between subgroups of patients. 
Mean values of VAS and EQ-5D were adjusted by medication group and 
HbA1c values, respectively, using analysis of covariance (ANCOVA). 
Variable medication group was dummy coded and entered as a scalar 
covariate in ANCOVA. The assumption of homogeneity of regression 
slope was tested using SPSS; custom model of ANCOVA was run 
using interaction term of covariate and independent variable. Other 
statistical assumptions were checked and compiled before running all 
SPSS tests.
RESULTS
Data of total 73 patients were analyzed for predicting the determinants 
of EQ-5D domains and VAS scores. Among the participants, 41.1% were 
males and 58.9% females. Mean HbA1c value of the participants was 
9.73%±1.48. Further descriptive statistics are shown in Table 1.
Out of total 73 patients, single summary index was obtained for 
56 patients only. The limitation was imposed by the lack of relevant 
Malaysian value set for the health states reported in our study [23]. 
Therefore, the descriptive data for these 56 participants involved in EQ-
5D mean score analysis have been presented separately.
EQ-5D domains
Fig. 1a and b shows the percentage of patients reporting problems 
in five domains of EQ-5D descriptive system for 73 and 56 patients, 
respectively. In Fig. 1a, patients most frequently reported to encounter 
problems in domain of pain (40.3%), followed by mobility (31.5%) and 
Table 1: Sociodemographic and clinical characteristics of the 
study participants




























Healthy (18.50–24.99) 26.1 26.8
Pre obese (25.00–29.99) 39.7 39.3
Obese (≥30.00) 34.2 33.9
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anxiety/depression (26.6%) domain. For 56 patients, the percentage of 
patients reporting problems was 36.4% in pain/discomfort, 28.6% in 
mobility, 25.5% in anxiety/depression, 12.5% in usual activities, and 
5.4% in self-care.
Determinants of problems in EQ-5D domains
Binary logistic regression analysis was carried out to predict the 
percentage of participants that reported problems in mobility using age 
gender, BMI, ethnicity, and presence of complications as predictors. Our 
H-L statistics had a significance value of 0.17 which shows this model 
is a good fit. Overall prediction success for the model was 77.8%. Age 
and BMI were significant predictors of reporting problems in mobility. 
None of the covariates in the model significantly affected the self-care. 
The presence of complications in participants significantly affected the 
reporting of problems in usual activities. Model showed the goodness of 
fit; HM stats value was 0.56 with 89% prediction success rate. Reporting 
problems in pain was significantly associated with HbA1c levels of the 
participants. HM statistics was 0.55 with overall prediction success 
of 63.9%. The presence of complications and having diabetes for 
5–10 years significantly determined the anxiety scores. HM statistics 
for goodness of fit was 0.86 with prediction success of 79.9%. Results 
have been presented in Table 2.
EQ-5D scores and VAS scores
The mean VAS score calculated from EQ-5D was 70.54. Medication 
group and HbA1c were found to be the significant predictors of mean 
VAS scores. VAS scores of all the characteristics listed in Table 3 were 
adjusted by these two variables. EQ-5D scores were associated with 
HbA1c values at a significant level (p=0.04), and mean EQ-5D scores of 
the characteristics were adjusted accordingly. VAS score was significantly 
lower in participants receiving both OHA and insulin treatment (69.46; 
CI 73.74, 84.02) than participants of OHA group (78.88; CI 64.94, 
73.98) (p=0.009). Unlike VAS scores, there was no difference in EQ-5D 
scores according to medication group. No differences in VAS scores 
were observed according to the presence or absence of diabetic 
complications. Mean EQ-5D score was slightly higher in the group with 
no diabetes complications (0.88; CI 0.82, 0.94) than the group with 
diabetes complications (0.89; CI 0.84, 0.94) (p=0.7, ns).
Participants with longer duration of diabetes reported highest VAS 
scores (<5 year = 72.21; 5–10 years = 72.83; more than 10 years 
= 75.39); however, the difference in scores with other groups was 
non-significant (p=0.71). Contrary to the VAS scores, highest EQ-5D 
scores were reported in the group with shortest duration of diabetes 
(<5 years = 0.93, CI 0.86–0.99; 5–10 years = 0.85, CI 0.78, 0.92; 
>10 years = 0.88, CI 0.82, 0.94) (p=0.23). BMI values in the range of 
obesity were associated with low EQ-5D scores than the BMI values 
in the range of healthy weight and pre-obesity; however, the change 
was non-significant (p=0.38). For VAS scores, lowest VAS score was 
reported in participants with a healthy weight (p=0.17, ns). There were 
no statistically significant differences in either VAS or EQ-5D scores 
Fig. 1: Response to EQ-5D domains. (a), 73 patients, (b), 56 patients
ba
Table 2: Patient characteristics and EQ-5D-3L domains (odds ratios, CI 95%)
Patient characteristics Mobility Self-care Usual activities Pain Anxiety
Age (years) (per 1 year 
increase)
1.08 (1.01–1.16)* 1.03 (0.93–1.15) 1.04 (1.01–1.18)* 1.05 (0.98–1.12) 0.99 (0.91–1.07)
Gender
(Female = 1 male = 0)
1.19 (0.37–3.85) 0.45 (0.07–3.17) 1.18 (0.22–6.33) 0.92 (0.33–2.56) 1.58 (0.40–6.31)
Presence of 
complications (yes = 1, no = 0)
2.75 (0.77–9.76) 2.74 (0.34–21.95) 12.31 (1.61–91.36)* 1.49 (0.41–5.39) 8.03 (1.34–48.02)*
BMI (Kg/m2)
(per 1 unit increase)













(OHA = 1, OHA + insulin = 0)
- - -
1.30 (0.45–3.80) 0.44 (0.09–1.97)









HbA1c - - 1.53 (.82–2.88) 1.55 (1.02–2.30)* 0.83 (0.48–1.43)
MMMAS - - - 1.07 (0.76–1.50) 0.91 (0.58–1.43)
*Means the values are statistically significant at P<0.05. Dotted line means variable was not included in the model
96
Asian J Pharm Clin Res, Vol 11, Issue 1, 2018, 93-98
 Butt et al. 
according to age groups and gender.
DISCUSSION
This study analyzed the association of HRQoL with patient characteristics 
in diabetes patients. It tried to examine and identify the factors that 
predict the quality of life in type 2 diabetes patients. The identification 
of predictive factors and their association patterns prove helpful in 
selecting the appropriate interventions to improve HRQoL. Our study 
uses a generic HRQoL instrument to facilitate the understanding of 
predictive factors of poor quality of life in poorly controlled diabetes 
patients in a tertiary care center in Malaysia. Majority of participants 
(57.7%) in our study were Malays, and this finding corresponds well 
with the distribution of the general population of Malaysia [3]. Diabetes 
patients reported to have a compromised HRQoL both by VAS scores 
and EQ-5D scores.
Among the five domains of health reported by EQ-5D, pain/discomfort 
was the domain where patients most frequently reported to encounter 
the problems. These results are consistent with the previous 
studies [21,25]. The presence of diabetes does not directly lead to pain; 
however, related complications and treatments such as peripheral 
neuropathies, delayed wound healing, and insulin injections can cause 
the pain and discomfort. Diabetic neuropathy is prevalent in diabetes 
and has been associated with the negative HRQoL [26]. More than 
half of the patients in our study were middle-aged or older; 38.4% of 
them had diabetes complications that can cause pain and discomfort. 
According to the results of regression analysis in our study, patients 
were 1.55 times more likely to report problems in pain/discomfort 
with an increase of each 1 unit in HbA1c (1.55; CI 1.02, 2.30) (p=0.043). 
Having higher HbA1c predisposes patients to the development of 
complications which in turn can lead to pain and discomfort. Pain is 
a significant determinant of poor quality of life, diabetes management 
interventions should not neglect this aspect, and concerted efforts 
should be made to alleviate its negative effects.
Next, domain most affected by diabetes in participants was mobility 
with 31.5% of patients reporting problems in this domain. Impaired 
mobility in diabetes is associated with decline in muscle power and 
neurophysiological functioning due to progressive nature of the disease 
and comorbidities [27,28]. Regression analysis in our study showed that 
increasing age and high BMI were significant predictors of problems 
in mobility. With each 1 unit increase in age, patients were 1.08 times 
more likely to report problems. Majority of our patients was middle-
aged or olderm thereby increasing the likelihood of the problems. 
73.9% of participants had a higher BMI than a healthy weight range, 
with each 1 unit increase in BMI, the participants are 1.15 times more 
at risk of encountering problems in mobility. Our findings are close to 
the finding of the study by Solli et al. [9]; the odds of having mobility 
problems were increased 1.12 times with an increase in BMI. Age is 
a factor which cannot be modified however a better activity planning 
should be done to slow down the mobility impairment. With regard to 
Table 3: Patient characteristics and EQ-5D score, VAS score
Patient 
characteristics 
VAS score (n=73) EQ-5D score (n=56)
Mean C1 95% p Mean±SD CI 95% p
73.70±15.12 (SD) 70.15, 77.26 0.89±0.13 0.85–0.92
Age groups
>51 69.31 62.35, 76.26 0.50 0.87 0.79, 0.96 0.98
51-56 76.27 69.87, 82.67 0.90 0.82, 0.97
56-62.5 74.79 67.77, 81.81 0.89 0.82, 0.97
>62.5 73.54 66.99, 80.09 0.88 0.80, 0.96
Gender
Female 73.10 68.71, 77.48 0.72 0.88 0.84, 0.94 0.99
Male 74.30 69.04, 79.57 0.88 0.83, 0.95
Ethnicity
Malay 74.76 70.33, 79.17 0.43 0.90 0.85, 0.95 0.60
Indian 70.89 63.76, 78.02 0.88 0.79, 0.96
Chinese 73.38 65.33, 81.43 0.86 0.77, 0.94
Duration of diabetes
<5 72.21 66.06, 78.37 0.71 0.93 0.86, 0.99 0.23
5-10 72.83 66.96, 78.70 0.85 0.78, 0.92
>10 75.39 69.86, 80.91 0.88 0.82, 0.94
Diabetes medication
OHA 78.88 73.74, 84.02 0.009* 0.088 0.82, 0.94 0.71
OHA + insulin 69.46 64.94, 73.98 0.89 0.84, 0.94
Presence of 
complications
Yes 73.64 68.22, 79.05 0.98 0.88 0.82, 0.94 0.77
No 73.57 69.29, 77.83 0.89 0.84, 0.94
BMI
Normal 68.15 61.52, 74.76 0.17 0.89 0.82, 0.97 0.38
Pre obese 75.27 70.02, 80.52 0.91 0.85, 0.97
Obese 75.78 70.10, 81.46 0.85 0.79, 0.92
Medication 
adherence
Non-adherent 75.19 70.51, 79.87 0.33 0.90 0.85, 0.95 0.74
Med/adherent 71.65 66.45, 76.84 0.87 0.82, 0.93
HbA1c
8–9 74.66 66.33, 82.98 0.68 0.95 0.86, 1.02 0.04*
>9–10 74.95 68.49, 81.39 0.90 0.83, 0.97
>10–11 69.20 60.81, 77.59 0.88 0.78, 0.96
>11 74.07 61.57, 86.59 0.70 0.56, 0.83
*Means values are statistically significant at p<0.05. ANCOVA; VAS scores adjusted by age and medication group. EQ-5D scores adjusted by HbA1c. OHA: Oral 
hypoglycemic agents, BMI: Body mass index
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BMI, the interventions for weight management should be undertaken 
by the patients to decrease the risk of mobility impairment.
Diabetes and depression/anxiety have been an active topic of interest 
for researchers. Previously, many studies have reported the negative 
impact of diabetes on the mental health of the patients [11,25,29]. 
Poor psychological well-being of the diabetes patients can stem from 
the constant worry about the progressive nature of the disease and 
development of complications. Consistent with a previous study [9], in 
our analysis, the presence of complications increased the likelihood of 
reporting problems in anxiety by 703 % (OR = 8.03). The participants in 
our study had a poorly controlled HbA1c; hence, the risk of developing 
complications was higher. Duration of diabetes also significantly 
predicted the problems in anxiety. Patient with 5–10 years of duration 
were 7.08 times more likely to report problems in anxiety compared to 
<5 years duration. There are conflicting results about the association of 
depression with duration of diabetes. Previously, patients with similar 
duration of diabetes have been shown to have odds ratio of 1.92 for 
the occurrence of depression in diabetes patients compared to their 
non-diabetes counterparts [30]. However, the results of both studies 
cannot be compared precisely, and our study evaluated the poorly 
controlled diabetes patients while other study compared the odds of 
having problems in diabetes patients against non-diabetes population. 
In a study by Katon [31], the duration of diabetes longer than 5 years 
increased the risk of depression by 10% compared to the group having 
<5 years duration. Some studies have reported the lack of any significant 
association between diabetes duration and depression [32,33]. In 
our study, the increased risk of anxiety in 5–10 years duration may be 
explained by the stage of diabetes in these years. The complications of 
diabetes start developing with the progress of time; our study had poorly 
controlled patients with higher chances of complications development 
during this phase compared to a shorter duration. There was an increased 
likelihood (OR = 1.58, CI 0.41, 6.38) of anxiety in female patients than the 
male patients; however, results were statistically non-significant.
A very small percentage of patients reported the problems in self-
care, and none of the covariates in the model significantly correlated 
with it. 13.7% of patients reported to have problems performing 
usual activities. Odds of having problems in usual activities increased 
1.04 times with each unit increase in age. Furthermore, if patients 
were experiencing diabetes comorbidities, they were 12.31 times more 
likely to report problems in conducting usual activities than the group 
without comorbidities. These findings are comparable to the other 
studies that investigated the impact of diabetes complications on usual 
activities and overall quality of life [9,34]. Our study did not analyze 
the relationship of individual complication with usual activities; the 
studies which give a detailed analysis can contribute more effectively 
toward this topic. Nevertheless, diabetes complications that hinder the 
performance of usual activities in the patients should be addressed to 
improve their overall HRQoL.
Our study found no significant association between patient 
characteristics and VAS except for the medication group; therefore, 
values of the variables in the equation were adjusted by the medication 
group. Consistent with the previous findings [18,35], patients using 
insulin along with OHAs reported a lower VAS score (69.46) than the 
group using OHAs only (78.88) (p=0.009). Initiation of insulin therapy 
becomes essential in many patients at some stage of their disease; it 
cannot be excluded from their treatment. Therefore, the interventions 
and/or educational strategies should include the assessment of patients 
about their treatment modalities. If patients report negative perception of 
insulin on their HRQoL, their concerns should be addressed. The negative 
perception about the use of insulin could be potentially explained by 
the unpleasantness of procedure and a need for lifestyle modifications. 
There is mixed evidence in the literature regarding this association. 
Some studies have reported lack of any significant association between 
treatment modality and VAS scores in the studies conducted at other 
places using EQ-5D [21,36]. Unlike the VAS scores, EQ-5D scores showed 
no difference between OHA and OHA plus insulin group. Instead, the EQ-
5D score was slightly lower (0.87) in OHA group compared to the other 
group (0.89) (p=0.17, ns). These findings are in agreement with the 
previous literature [21,22,36,37] that reported no significant association 
between HRQoL and treatment type using EQ-5D scores. Among the 
other substantial differences that were non-significant, patients with 
healthy weights reported a lower VAS scores than the pre-obese or obese 
patients; a higher VAS mean value was recorded in the non-adherent 
patients than the medium or adherent patients.
Patients reported a mean EQ-5D score of 0.89; EQ-5D scores were 
significantly determined by HbA1c values in this study (p=0.04). 
Post hoc study of the HbA1c groups showed patients with HbA1c >11 
had significantly lower EQ-5D values (0.70) than the patients in the 
group with HbA1c 9-10 (0.90) (p=0.041). This finding is congruent with 
the previous studies which reported that higher HbA1c was associated 
with a lower EQ-5D score [25,35]. Having higher levels of HbA1c 
can contribute to the low HRQoL by either predisposing the patients 
to a higher risk of complications or imparting anxiety to them about 
the failure of glycemic control. Among other reasonable differences 
between groups that were non-significant, obese patients reported 
lower mean EQ-5D scores (0.85) than pre-obese (0.91) and healthy 
weight group (0.89); patients with diabetes duration <5 years reported 
higher HRQoL than the other groups with longer diabetes duration; 
and Malays had a higher score (0.90) than Indian (0.88) and Chinese 
(0.88) ethnic groups. In our study, although the difference among 
ethnicities did not reach statistical significance, the results were similar 
to a Malaysian study that reported highest HRQoL life scores for Malay, 
followed by Indians and Chinese [19].
Limitations of the study
This study had comparatively smaller sample size, and no sample 
calculations were performed. However, it can serve as preliminary/
pilot data about the similar studies at a bigger scale. It is important 
to interpret the results of the study with caution since the EQ-5D 
instrument is not diabetes-specific and compromised HRQoL scores 
may reflect the impact of unrelated comorbidity.
CONCLUSION
This study provides knowledge about the determinant of HRQoL in 
diabetes patients. Diabetes patients in this study frequently reported 
problems in pain/discomfort followed by anxiety/depression. 
Furthermore, it provides the HRQoL utility data for comparison of health 
states in diabetes patients across similar studies. Among modifiable 
factor, our study found a significant and inverse association of HRQoL 
with medication group (insulin use), high HbA1c, obesity, and presence 
of complications. These results were supported by the existing literature. 
Therefore, it is reasonable to conclude that health-care interventions 
directed at preventing or adjusting insulin use, high HbA1c, obesity, and 
presence of complications will improve HRQoL indicators.
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